These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3361352

  • 1. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
    Sato M, Kaji R, Urata M, Yoshida H, Yanagawa T, Miyamoto K, Azuma M, Furumoto N, Saito M.
    J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R, Yoshida H, Yanagawa T, Sato M.
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M, Ohe G, Furuichi S, Nishikawa H, Oshikawa T, Tano T, Ahmed SU, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    Anticancer Res; 2002 Oct; 22(6A):3229-39. PubMed ID: 12530069
    [Abstract] [Full Text] [Related]

  • 4. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec 20; 24(11):2546-55. PubMed ID: 2614190
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
    Okamoto M, Kaji R, Kasetani H, Yoshida H, Moriya Y, Saito M, Sato M.
    J Immunother Emphasis Tumor Immunol; 1993 May 04; 13(4):232-42. PubMed ID: 8334107
    [Abstract] [Full Text] [Related]

  • 6. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May 04; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 7. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T, Okamoto M, Ohe G, Furuichi S, Nishikawa H, Uddin Ahmed S, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    Int Immunopharmacol; 2003 May 04; 3(5):643-55. PubMed ID: 12757734
    [Abstract] [Full Text] [Related]

  • 8. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N, Saito M, Nanjo M.
    Gan To Kagaku Ryoho; 1984 Dec 04; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [Abstract] [Full Text] [Related]

  • 9. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
    Okamoto M, Gohda H, Ohe G, Yoshida H, Matsuno T, Saito M, Sato M.
    J Immunother; 2000 Jan 04; 23(1):94-103. PubMed ID: 10687142
    [Abstract] [Full Text] [Related]

  • 10. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1988 Apr 04; 58(2):109-14. PubMed ID: 3261814
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov 04; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 12. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T, Blancher A, Calvas P, Neulat-Duga I, Delsol G.
    Ann Pathol; 1987 Nov 04; 7(1):1-8. PubMed ID: 3040026
    [Abstract] [Full Text] [Related]

  • 13. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun 04; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 14. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K, Kano S, Takaku F, Okumura K.
    J Natl Cancer Inst; 1980 Dec 04; 65(6):1265-9. PubMed ID: 7001124
    [Abstract] [Full Text] [Related]

  • 15. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y, Hirata H, Sakamoto K, Sato M, Morikage T, Maruyama M, Sasaki K, Yano S.
    Gan To Kagaku Ryoho; 1987 Sep 04; 14(9):2710-5. PubMed ID: 3631971
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y, Eto M, Maeda T, Hiromatsu K, Kobayashi N, Nomoto K, Kong YY, Nomoto K.
    Immunology; 1994 Oct 04; 83(2):196-204. PubMed ID: 7835935
    [Abstract] [Full Text] [Related]

  • 17. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
    Yamaue H, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Inoue M.
    Biotherapy; 1990 Oct 04; 2(1):51-61. PubMed ID: 2400628
    [Abstract] [Full Text] [Related]

  • 18. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.
    Seaman WE, Sleisenger M, Eriksson E, Koo GC.
    J Immunol; 1987 Jun 15; 138(12):4539-44. PubMed ID: 3584981
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov 15; 79(5):1019-24. PubMed ID: 3500354
    [Abstract] [Full Text] [Related]

  • 20. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H, Naito K, Maeda Y, Kobayashi M, Kurioka H, Fujimori C, Tanaka T, Hashimoto I.
    Gan To Kagaku Ryoho; 1983 Jul 15; 10(7):1670-8. PubMed ID: 6870309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.